<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>It has been reported that many <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e>) patients with synchronous or metachronous <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> underwent surgery subsequent to neoadjuvant combination chemotherapy with folinic acid, fluorouracil, and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (FOLFOX), folinic acid, fluorouracil, and irinotecan (FOLFIRI), or <z:chebi fb="0" ids="31348">capecitabine</z:chebi> and <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> (XELOX) </plain></SENT>
<SENT sid="1" pm="."><plain>However, there are very few reports of the use of <z:chebi fb="0" ids="31348">capecitabine</z:chebi> and irinotecan (XELIRI) </plain></SENT>
<SENT sid="2" pm="."><plain>We herein report a successfully resected case of recurrent lung and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> of <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> treated with combination chemotherapy with XELIRI + bevacizumab (BV) therapy </plain></SENT>
<SENT sid="3" pm="."><plain>A 63-year-old male developed recurrence of a solitary nodule in the right lower lobe of the lung and multiple <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> after low anterior resection for <z:e sem="disease" ids="C0007113" disease_type="Neoplastic Process" abbrv="">rectal cancer</z:e> 1 year previously </plain></SENT>
<SENT sid="4" pm="."><plain>Partial resection of the right lower lobe of the lung was performed and treatment with XELIRI + BV was initiated </plain></SENT>
<SENT sid="5" pm="."><plain>A computed tomography scan revealed a reduction in <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size without any new lesions after four cycles of XELIRI + BV therapy </plain></SENT>
<SENT sid="6" pm="."><plain>Partial hepatectomy of S1, S5, and S7 was safely performed </plain></SENT>
<SENT sid="7" pm="."><plain>The patient is now undergoing adjuvant chemotherapy and has been free from recurrence for 18 months following surgery </plain></SENT>
<SENT sid="8" pm="."><plain>There are only few studies with relatively low patient numbers reporting on the outcome after resection of both pulmonary and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">CRC</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>We therefore report a patient who underwent sequential resection of pulmonary and <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">hepatic metastases</z:e> with XELIRI + BV therapy </plain></SENT>
</text></document>